Leptin, a hormone produced in white adipose tissue, acts in the brain to communicate fuel status, suppress appetite following a meal, promote energy expenditure and maintain blood glucose stability 1,2 . Dysregulation of leptin or its receptors (LEPR) results in severe obesity and diabetes 3-5 . Although intensive studies on leptin have transformed obesity and diabetes research 2,6 , clinical applications of the molecule are still limited 7 , at least in part owing to the complexity and our incomplete understanding of the underlying neural circuits. The hypothalamic neurons that express agouti-related peptide (AGRP) and pro-opiomelanocortin (POMC) have been hypothesized to be the main first-order, leptin-responsive neurons. Selective deletion of LEPR in these neurons with the Cre-loxP system, however, has previously failed to recapitulate, or only marginally recapitulated, the obesity and diabetes that are seen in LEPR-deficient Lepr db/db mice, suggesting that AGRP or POMC neurons are not directly required for the effects of leptin in vivo 8-10 . The primary neural targets of leptin are therefore still unclear. Here we conduct a systematic, unbiased survey of leptinresponsive neurons in streptozotocin-induced diabetic mice and exploit CRISPR-Cas9-mediated genetic ablation of LEPR in vivo. Unexpectedly, we find that AGRP neurons but not POMC neurons are required for the primary action of leptin to regulate both energy balance and glucose homeostasis. Leptin deficiency disinhibits AGRP neurons, and chemogenetic inhibition of these neurons reverses both diabetic hyperphagia and hyperglycaemia. In sharp contrast to previous studies, we show that CRISPRmediated deletion of LEPR in AGRP neurons causes severe obesity and diabetes, faithfully replicating the phenotype of Lepr db/db mice. We also uncover divergent mechanisms of acute and chronic inhibition of AGRP neurons by leptin (presynaptic potentiation of GABA (γ-aminobutyric acid) neurotransmission and postsynaptic activation of ATP-sensitive potassium channels, respectively). Our findings identify the underlying basis of the neurobiological effects of leptin and associated metabolic disorders.
. In addition, similar expression patterns were seen in the brains of non-obese diabetic (NOD) mice (Extended Data Fig. 1m-r) , in which diabetes is caused by insulitis 14 .
To identify neurons primarily affected by leptin deficiency, we administered leptin in STZ-treated mice. The molecular changes in neuronal activity in STZ-treated mice were broadly corrected 24 h after leptin infusion, whereas leptin treatment for as little as 3 h reversed only the changes in the arcuate nucleus (ARC), and not those in the adjacent lateral hypothalamus (LH) or the dorsomedial hypothalamus (DMH) ( Fig. 1a, b ; Extended Data Fig. 1i-l) , indicating that the ARC contains the majority of neurons that respond directly to leptin stimulation.
We hypothesized that neurons that express FOS and pS6 in the ARC, at least in part, are AGRP neurons, given that STZ induces: 1) the loss of insulin and leptin (Extended Data Fig. 1c, g) , both of which inhibit AGRP neurons [15] [16] [17] ; 2) increased expression of Agrp and Npy mRNA in the mediobasal hypothalamus (Extended Data Fig. 2a ); and 3) severe diabetic hyperphagia during both light and dark cycles (Extended Data Fig. 2b-f , Supplementary Video 1), mirroring the voracious feeding in mice with activated AGRP neurons 18, 19 . To investigate this, we treated Npy-hrGFP transgenic mice on the basis that they faithfully co-express AGRP and neuropeptide Y (NPY) in the ARC 20 . Indeed, AGRP neurons were remarkably activated, as judged by intensive expression of FOS and pS6, depolarization, and increased firing rates ( Fig. 1c -e, Extended Data Fig. 2g -i). To determine the pathological relevance of activated AGRP neurons, we injected an adeno-associated virus vector (AAV) carrying a Cre-dependent hM4Di-mCherry transgene 19 bilaterally into the ARC of Agrp-IRES-cre mice, followed by STZ treatment (Extended Data Fig. 2j ). Stimulation of hM4Di with clozapine-N-oxide (CNO), thereby inhibiting AGRP neurons, attenuated FOS expression in the ARC (Fig. 1g, h) , suppressed diabetic hyperphagia ( Fig. 1i , Extended Data Fig. 2k , l) and notably reduced hyperglycaemia ( Fig. 1j , k, Extended Data Fig. 2m ). CNO injection into STZ-treated, AAV-FLEX-mCherry-transduced mice elicited no obvious changes in these parameters (Extended Data Fig. 2n-q) . These results demonstrate that AGRP neurons represent the main ARC neurons that are primarily disinhibited by leptin deficiency, and that their enhanced firing rate contributes essentially to both diabetic hyperphagia and hyperglycaemia.
These findings, however, contradict the prevailing view that AGRP neurons are dispensable for the action of leptin in the brain, as selectively disrupting LEPR in AGRP neurons has previously failed to recapitulate either obesity or diabetes in Lepr db/db mice 9 . We then used CRISPR gene-editing technology 21 to re-examine leptin action and to avoid potential compensatory effects 22, 23 . We constructed an AAV carrying a single-guide RNA (sgRNA) targeting the mouse Lepr locus and a Cre-dependent mCherry reporter to indicate virus-transduced neurons (AAV-sgLepr, Fig. 2a, Extended Data Fig. 3a ). To examine the efficacy of CRISPR-mediated deletion of LEPR, we mated Agrp-IRES-cre mice with Cre-enabled Rosa26-LSL-Cas9-GFPknockin mice 24 to specifically express Cas9 endonuclease in AGRP neurons, and unilaterally injected AAV-sgLepr into the ARC of
Letter reSeArCH
Agrp-IRES-cre::LSL-Cas9-GFP offspring (Extended Data Fig. 3b ). We found that reduced expression of Lepr mRNA, attenuated leptininduced phosphorylation of STAT3 (pSTAT3, a marker for LEPR activity) and increased FOS (a marker to indicate disinhibition of neurons) were restricted to the virus-transduced ARC, but not in the contralateral ARC without AAV, nor in the adjacent DMH, which lacked Cre activity (Extended Data Fig. 3c-h) , demonstrating effective, neuron-type-specific disruption of LEPR with CRISPR.
To assess the functional relevance of LEPR in AGRP neurons, we injected AAV-sgLepr bilaterally into the ARC of Agrp-IRES-cre and Agrp-IRES-cre::LSL-Cas9-GFP littermates (Fig. 2b) . Extensive co-localization of Cre-enabled mCherry and leptin-induced pSTAT3 was largely diminished in virus-transduced AGRP neurons expressing Cas9 (Fig. 2c, d) . Notably, CRISPR-mediated deletion of LEPR in AGRP neurons induced severe hyperleptinaemia, obesity and diabetes, as evidenced by increased fat mass, body weight and daily food intake, reduced energy expenditure and brown adipose tissue activity, elevated serum levels of leptin, insulin and blood glucose, impaired glucose tolerance and extreme insulin resistance in both male and female mice ( Fig. 2e -l, Extended Data Fig. 3i-m) . These effects are not a result of CRISPR-mediated off-site mutagenesis, as AGRP neuron-specific expression of a CRISPR-insensitive Lepr transgene (ciLepr) encoding the long-form LEPR completely prevented such changes in body weight, feeding and blood glucose (Extended Data Fig. 4a-k) . As an additional comparison, we injected AAV in parallel into the ARC of Lepr db/db mice of the same age. Mice with disrupted LEPR in AGRP neurons exhibited around 81% of the weight gain ( Fig. 2m ), around 85% of the hyperphagia and around 61% of the hyperglycaemia (Extended Data Fig. 3n -p) that is seen in mice that completely lack LEPR (Lepr db/db ), demonstrating that the lack of LEPR in AGRP neurons has a major role in the development of obesity in Lepr db/db mice. To determine whether LEPR in AGRP neurons is also required for leptin to reverse STZ-induced diabetes, we transduced these neurons with AAV-sgLepr, followed by STZ treatment and implantation of an osmotic pump to chronically infuse leptin centrally ( Fig. 2n , Extended Data Fig. 3q ). In control diabetic mice, leptin infusion reversed the extreme hyperglycaemia, consistent with previous findings 11 ; this effect, however, was abolished in mice expressing Cas9 in AGRP neurons, as was the ability of leptin to restore other catabolic consequences ( Fig. 2o food intake (h), oxygen consumption (i), ad libitum-fed blood glucose levels (j), glucose-tolerance test (k) and insulin-tolerance test (l) at eight weeks post-injection with AAV-sgLepr (n = 9 mice per group). m, Growth curve following AAV-sgLepr injection into the ARC of four-week-old Agrp-IRES-cre (Cas9 − ), Agrp-IRES-cre::LSL-Cas9-GFP (Cas9 + ), Lepr db/+ (db/+) and Lepr db/db (db/db) mice (n = 9 mice per group). n, o, Schematic diagram and blood glucose measurement in STZ-treated, virus-transduced Agrp-IRES-cre (Cas9 − ) and Agrp-IRES-cre::LSL-Cas9-GFP mice (Cas9 + ) mice following chronic administration of saline or leptin into the lateral ventricle by implanted osmotic pump (n = 9 mice per group). Data are mean ± s.e.m. and representative of three independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; Student's two-tailed, unpaired t-test (d, f, g insert, h, j) or two-way ANOVA (g, k, l, m, o) with Šidák post hoc test (k).
Data Fig. 3r , s). Leptin-induced chronic effects on body weight and food intake were also impaired in animals without STZ treatment (Extended Data Fig. 3t -v). Lastly, we performed CRISPR-mediated deletion of LEPR in ARC POMC neurons and observed no effects either on body weight or on blood glucose, indicating that LEPR in POMC neurons is dispensable (Extended Data Fig. 5a -j). These findings demonstrate that leptin acts primarily on AGRP neurons to maintain energy and glucose homeostases, preventing both obesity and diabetes.
How does leptin inhibit AGRP neurons? Leptin has been shown to hyperpolarize hypothalamic neurons by opening ATP-sensitive potassium channels (K ATP ) in acute rat brain slices 25 ; however, global deletion of the K ATP channel subunits Kir6.2 (also known as KCNJ11) or SUR1 in mice results in only slightly impaired glucose tolerance, without notable changes in body weight 26, 27 . To interrogate the functional relevance of K ATP in AGRP neurons, we constructed an AAV carrying an sgRNA targeting the mouse Kcnj11 locus and a Cre-dependent mCherry transgene (AAV-sgK ATP ) to achieve CRISPR-mediated deletion of the pore-forming subunit Kir6.2 (Fig. 3a ). Following unilateral injection of AAV-sgK ATP into the ARC of Agrp-IRES-cre::LSL-Cas9-GFP mice, virus-transduced AGRP neurons exhibited increased FOS expression, depolarization, and firing rates in ad libitum-fed mice, and no responses to a K ATP opener, diazoxide, which induced hyperpolarization and reduced firing of AGRP neurons in fasted animals, compared to the contralateral control neurons ( Fig. 3b-d ), suggesting functional disruption of K + efflux. Leptin-induced phosphorylation of STAT3 was not obviously affected (Extended Data Fig. 6a ). Following bilateral AAV injection, we observed severe hyperleptinaemia, obesity and diabetes in mice expressing Cas9 in AGRP neurons ( Fig. 3e -n), comparable to the phenotypes observed in mice following AGRP-neuron-specific LEPR disruption ( Fig. 2e-l ). Expression of a CRISPR-insensitive Kcnj11 transgene (ciKcnj11) in AGRP neurons following CRISPR-mediated deletion of Kcnj11 prevented the changes in body weight, feeding and blood glucose, excluding possible effects of CRISPR-mediated off-site mutagenesis (Extended Data Fig. 6c -k). To determine whether K ATP channels in AGRP neurons are required for the actions of leptin, we monitored changes in body weight and food intake following three consecutive days of leptin or saline injection (Extended Data Fig. 6b ). Whereas leptin markedly reduced body weight and food intake in the control group, it had no effects on mice with disrupted K ATP channels in AGRP neurons ( Fig. 3o, p) . These results demonstrate that K ATP channels negatively regulate AGRP neurons, and that their absence in :LSL-Cas9-GFP mice. K ATP channel opener diazoxide was applied as indicated (n = 12 neurons per group from four mice). c, d, mCherry and FOS co-immunostaining and representative traces of brain-slice whole-cell current-clamp recordings (c) in AGRP neurons from Agrp-IRES-cre::LSL-Cas9-GFP mice that had been injected unilaterally into the ARC with AAV-sgK ATP , and quantification of frequency and membrane potential (d). n = 10 neurons per group from three mice. e-n, AAV-sgK ATP was injected bilaterally into the ARC of Agrp-IRES-cre::LSL-Cas9-GFP mice, which was co-immunostained for mCherry and GFP (e). Representative littermates (f), serum leptin levels (g), body weight (h), fat mass (i), daily food intake (j), ad libitum-fed state blood glucose levels (k), serum insulin levels (l), glucose-tolerance test (m), and insulin-tolerance test (n) at eight weeks post-viral injection. n = 9 mice per group. o, p, Body weight and daily food intake changes during three-day treatment with leptin versus saline control of Agrp-IRES-cre (Cas9 − ) and Agrp-IRES-cre::LSL-Cas9-GFP mice (Cas9 + ) mice (n = 9 mice per group). Data are mean ± s.e.m. and representative of three independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; Student's two-tailed, unpaired t-test (b, c, g, i-l) or twoway ANOVA (o, p) with Šidák post hoc test (h, m, n).
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Leptin inhibits hunger-induced appetite and suppresses overeating following an acute fasting period. This effect of leptin, however, was unchanged in mice with disrupted K ATP channels in AGRP neurons (Extended Data Fig. 7a ), suggesting an alternative mechanism. Since picrotoxin-sensitive spontaneous inhibitory postsynaptic currents (sIPSCs) in AGRP neurons were markedly reduced following fasting when circulating leptin levels were low, and were restored by further incubation with leptin ( Fig. 4a , Extended Data Fig. 7b , c), we considered GABAergic afferent modulation of AgRP neurons as an additional option 28 . Owing to the complex composition of GABA A receptors, to our knowledge it is not possible yet to achieve genetic ablation of total ionotropic GABAergic neurotransmission in neurons 29 (Extended Data Fig. 7d ). To investigate the physiological relevance of GABAergic neurotransmission on AGRP neurons, we constructed an AAV carrying three concatenated sgRNAs targeting the mouse loci (Gabrb1, Gabrb2 and Gabrb3) that encode the three GABA A receptor β-subunits, and a Cre-dependent mCherry transgene (AAV-sgGABA A -R) ( Fig. 4b , Extended Data Fig. 7e ). Following unilateral injection of the AAV into the ARC of Agrp-IRES-cre::LSL-Cas9-GFP mice, sIPSCs were eliminated from virus-transduced AGRP neurons (Fig. 4b, c ), suggesting rapid, effective disruption of postsynaptic GABA A receptors by CRISPR. Bilateral deletion of GABA A receptors in AGRP neurons induced a transient increase in body weight and a short-term increase in daily food intake, both of which disappeared four weeks after AAV injection, probably owing to a compensatory balance established between excitatory and inhibitory synaptic transmission (Extended Data Fig. 8a-e ). During the experimental period, leptin did not exhibit acute suppression of hunger-induced appetite in virus-transduced mice expressing Cas9 (Fig. 4d ), but its chronic effects on body weight and food intake remained unaffected (Extended Data Fig. 9a, b ). This loss of function was prevented by expression of a CRISPR-insensitive Gabrb3 transgene (ciGabrb3) in AGRP neurons, which restored GABAergic neurotransmission (Extended Data Fig. 9c -k), demonstrating that GABAergic afferents on AGRP neurons are necessary for the acute inhibition of appetite by leptin.
Finally, we investigated modulation by leptin of GABAergic afferents on AGRP neurons. In fasted mice, but not in ad libitum-fed mice, leptin suppressed the paired-pulse ratio of electrically evoked IPSCs (eIP-SCs), suggesting that there is presynaptic potentiation of GABA release ( Fig. 4e , Extended Data Fig. 9l ). Since some LEPR-expressing neurons in the ventral DMH (vDMH) are GABAergic 10 and monosynaptically innervate AGRP neurons 30 (Extended Data Fig. 9m , n), we injected . h-j, AAV pU6-sgRNA Lepr ::pEF1α-FLEX-mCherry and Cre-dependent AAV pMeCP2-FLEX-spCas9 were injected unilaterally into the vDMH of Vgat-IRES-cre mice to disrupt presynaptic leptin receptors (h), which were co-immunostained for mCherry and leptin-induced pSTAT3 (i, j; n = 4 mice). k, Post-fast refeeding study in mice injected bilaterally in the vDMH of dual-virus-transduced Vgat-IRES-cre (Cas9 − ) and Vgat-IRES-cre::LSL-Cas9-GFP (Cas9 + ), following administration of saline or leptin (n = 7 mice per group). Data are mean ± s.e.m. and representative of three independent experiments; **P < 0.01, ***P < 0.001, ****P < 0.0001; Student's two-tailed, unpaired t-test (c, d, e, j, k) or Student's two-tailed, paired t-test (g).
AAV-FLEX-hM4Di-mCherry into the vDMH of Vgat-IRES-cre:: Npy-hrGFP mice to specifically transduce GABAergic neurons in this nucleus (vGAT vDMH , Fig. 4f ). Inhibition of these neurons upon incubation with CNO eliminated the majority of sIPSCs recorded in AGRP neurons ( Fig. 4g ), suggesting that vGAT vDMH neurons represent the dominant source of GABAergic afferents. We simultaneously transduced vGAT vDMH neurons with AAV-sgLepr and a Cre-dependent AAV carrying an spCas9 transgene and effectively deleted LEPR as revealed by the decrease in leptin-induced pSTAT3 (Fig. 4i, j) . Residual LEPR activity presumably comes from non-GABAergic neurons in the DMH 10 . Disruption of LEPR in vGAT vDMH neurons prevented leptin-mediated inhibition of fasting-induced overeating (Fig. 4k ), replicating the results obtained in mice following postsynaptic GABA A receptor deletion (Fig. 4d ). These results indicate that leptin also engages presynaptic potentiation of GABA release to inhibit AGRP neurons and to suppress hunger-induced appetite.
The present study, summarized in Extended Data Fig. 9o , identifies the fundamental component of the neural circuits governing energy and blood glucose regulation and will facilitate future studies seeking therapeutic interventions for obesity and diabetes. The disparity in phenotypes following CRISPR-mediated gene-editing also highlight the need for a careful re-examination of previous conclusions drawn from conventional genetic ablation studies.
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Mice. All animal care and procedures were performed in accordance with national and international guidelines and were approved by the Tufts University/ Tufts Medical Center Institutional Animal Care and Use Committee (IACUC), in accordance with NIH guidelines. Mice were group housed (2-5 siblings) at 22-24 °C with a 12-h light-dark cycle, and with ad libitum access to a regular chow diet and water. All diets were provided as pellets. Mice were euthanized by CO 2 narcosis. Agrp-IRES-cre 31 (Jax, 012899), Npy-hrGFP 20 (Jax, 006417), Pomc-hrGFP 32 (Jax, 006421), Pomc-cre 8 (Jax, 010714) and Vgat-IRES-cre 10 (Jax, 016962) mice were previously generated at the BNORC transgenic core and are available at the Jackson Laboratory. Rosa26-LSL-Cas9-GFP 24 (Jax Stock No: 024857) knock-in, NOD 33 (Jax Stock No: 001976), Lepr db/db (Jax Stock No: 000642) and C57BL/6 (Jax Stock No: 000664) mice were obtained from the Jackson Laboratory. Males of mouse lines were used for experiments, and some female mice were used for clinically relevant experiments, particularly with the Agrp-IRES-cre and NOD mouse lines. Following stereotaxic injection to express AAVs, mice were individually housed with ad libitum access to regular chow diet and water. Littermates of the same sex were randomly assigned to either experimental or control groups. Virus production. Cre-dependent AAV viral vectors were constructed based on pAAV-pEF1α-FLEX-mCherry-WPRE-pA plasmid 34 . For the AAVs to deliver sgRNAs into the hypothalamus, sgRNAs were designed using online CRISPR tools 35, 36 (http://crispr.mit.edu/ and http://chopchop.cbu.uib.no/). The pU6-sgR-NA-scaffold cassettes for expressing single or concatenated sgRNAs, including those in AAV vectors AAV-pU6-sgRNA Lepr ::pEF1α-FLEX-mCherry, AAV-pU6-sgRNA Kcnj11 ::pEF1α-FLEX-mCherry, and AAV-pU6-sgRNA Gabrb1/2/3 ::pEF1α-FLEX-mCherry, were constructed using an in-house designed 'snap-ligation' kit, followed by cloning into the MluI site on pAAV-pEF1α-FLEX-mCherry-WPRE-pA plasmid. For the AAVs to express CRISPR-insensitive (ci) cDNAs in Cre-expressing neurons, including AAV-pEF1α-FLEX-ciLepr, AAV-FLEX-ciKcnj11, and AAV-pEF1α-FLEX-ciGabrb3, cDNAs were generated from the total RNAs extracted from the hypothalamus of C57BL/6 mice by reverse transcription. The DNA fragments containing coding DNA sequences of Lepr (encoding the long-form leptin receptor, LEPRB), Kcnj11 (encoding Kir6.2), and Gabrb3 (encoding GABA A receptor β3 subunit) were amplified with the following pairs of PCR primers: Lepr-fwd: tttaaaaggatttgcagcgg and Leprrev: atgacaggctctactggaat; Kcnj11-fwd: ggtagacttatcccgccgtg and Kcnj11-rev: cctaggccaagccagtgtag; Gabrb3-fwd: gaagggatgtggggctttgcg and Gabrb3-rev: agcccatcacagagaagcca. Second PCR reactions were performed to introduce silent mutations in sgRNA-binding sites with the following primers: ciLepr-fwd: atgatgtgtcagaaattctatgtggttttgttacactgggaatttctttatgtgatagctgcacttaacctggcatatccaatc tctccctggaaatttaagttgttttgtggaccccccaataccacagacgatagctttctctcacctgctggagcccc and ciLepr-rev: attacacagttaagtcacac; ciKcnj11-fwd: atgctgtcccgaaagggcattatccctga ggaatatgtgctgacccggctggcaggggaccctgcagagccacgatatagaacgagggaacggagggcccgcttcg tgtccaagaaaggcaac and ciKcnj11-rev: tcaggacaaggaatctggag; ciGabrb3-fwd: atgtggg gctttgcgggaggaaggcttttcggcatcttctcggccccggtgctggtggcggtggtttgctgcgctcagagcgtaaa cgaccccgggaacatgtcctttgtgaaggagacggtcgacaagctgttgaaaggctacgacataagattacgtccaga ttttgggggtcccccagtctgcgtggggatg and ciGabrb3-rev: tcagttaacatagtacagccag. Following Sanger DNA sequencing to verify the mutations, the obtained DNA fragments were ligated into the AscI and NheI restriction enzyme sites of pAAV-pEF1α-FLEX-mCherry-WPRE-pA plasmid. The listed AAV vectors were packaged at the Boston Children's Hospital Viral Core. For CRISPR-insensitive GABA A receptor subunit re-expression experiments following CRISPR-mediated deletion in AGRP neurons, cDNA encoding GABA A receptor β3 subunit was selected since this subunit is abundantly expressed in AGRP neurons according to a recent gene-profiling study 37 . The construction and generation of AAV-FLEX-spCas9 virus will be reported elsewhere (C.-H. Chieng, unpublished data). AAV-pSyn-FLEX-hM4Di-mCherry 19 virus was generated from University of North Carolina Vector Core. AAV-pEF1α-FLEX-Synaptophysin-mCherry 38 virus was obtained from MIT Viral Gene Transfer Core. In addition, the following were used (AAV coat serotypes, titre viral molecules/ml): pU6-sgRNA Lepr ::pEF1α-FLEX-mCherry (2/8, 1.9 × 10 14 ), pU6-sgRNA Kcnj11 ::pEF1α-FLEX-mCherry (2/8, 7.2 × 10 14 ), pU6-sgRNA Gabrb1/2/3 ::pEF1α-FLEX-mCherry (2/8, 1.7 × 10 15 ), AAV-FLEX-ciLepr (DJ, 8.5 × 10 13 ), AAV-FLEX-ciKcnj11 (DJ, 2.2 × 10 14 ), AAV-FLEX-ciGabrb3-GFP (DJ, 1.9 × 10 14 ), AAV-FLEX-SpCas9 (DJ, 1.8 × 10 14 ) and AAV-hSyn-FLEX-hM4Di-mCherry (2/8, 6.7 × 10 12 ). Viral aliquots were stored at −80 °C before stereotaxic injection. Stereotaxic surgery. Stereotaxic surgery to deliver AAV into the hypothalamus of mice was performed as previously described 39 . In brief, 4-8-week-old mice were anaesthetized with ketamine (75 mg/kg) and xylazine (5 mg/kg) diluted in saline (0.9% NaCl in water) and fixed on a stereotaxic apparatus (KOPF model 922) with ear-bars. After exposing the skull via a small incision, a small hole was drilled for injection based on coordinates to bregma. A pulled-glass pipette with 20-40-μm tip diameter was inserted into the brain and AAV viruses (50-150 nl per injection site) were injected by an in-house-built air-puff system. A micromanipulator (Grass Technologies, Model S48 Stimulator) was used to control injection speed at 25 nl/min and the pipette was left in position for another 5 min to allow enough absorption and spreading of AAVs before being withdrawn. For postoperative care, mice were injected intraperitoneally with meloxicam (0.5 mg/kg) for two continuous days. All stereotaxic injection sites were verified under electrophysiological microscopy (for electrophysiology-related studies) or by immunohistochemistry (for anatomy and in vivo studies). All 'missed' or 'partial-hit' animals were excluded from data analyses. Animals were allowed to recover from surgery for 1 week and their body weight and health conditions were closely monitored during recovery. Coordinates and injection volume used in the studies are: the ARC (anterior-posterior (AP): −1.40 mm, dorsal-ventral (DV): −5.80 mm, left-right (LR): ± 0.30 mm, 150 nl/side) and the vDMH (AP: −1.80 mm, DV: −5.30 mm, LR: ± 0.30 mm, 50 nl/side). Brain slice preparation and electrophysiology. Mice less than eight weeks of age were anaesthetized by inhalation of isoflurane. Coronal sections (300-μm-thick) were cut with a Leica VT1000S vibratome and then incubated in carbogensaturated (95% O 2 /5% CO 2 ) ACSF (in mM: 125 NaCl, 2.5 KCl, 1 MgCl 2 , 2 CaCl 2 , 1.25 NaH 2 PO 4 , 25 NaHCO 3 , 10 glucose) at 34 °C for 30-45 min before recording. All recordings were obtained within 4 h of slicing at room temperature. Whole-cell recordings were obtained from arcuate AGRP neurons visualized under infrared differential interference contrast (IR-DIC) using patch pipettes with pipette resistance of 2.5-4.5 MΩ. To identify infected AGRP neurons, mCherry or GFP fluorescence or both were detected using epifluorescence illumination. For sIPSC and sEPSC recordings, the internal solution contained (in mM) 135 CsMeSO 3 , 10 HEPES, 1 EGTA, 3.3 QX-314 (Cl − salt), 4 Mg-ATP, 0.3 Na-GTP, 8 Na 2phosphocreatine (pH 7.3 adjusted with CsOH; 295 mOsm kg −1 ). For current-clamp recordings, the internal solution consisted of (in mM) 135 KMeSO 3 , 3 KCl, 10 HEPES, 1 EGTA, 0.1 CaCl 2 , 4 Mg-ATP, 0.3 Na-GTP, 8 Na 2 -phosphocreatine (pH 7.3 adjusted with KOH; 295 mOsm kg −1 ). For K ATP knockout identification, mice were fasted for 24 h to activate AGRP neuronal activities before brain slice preparation. Diazoxide (Sigma D9035) was added to the bath solution (300 μM). For leptin-induced sIPSC recording, mice were fasted for 24 h and 100 nM mouse leptin was added into bath solution. Mouse leptin was purchased from A. Parlow (NHHP, NIDDK) as 1-mg powder aliquots. A stock solution of 78 μM was made by dissolving 1 mg leptin with 500 μl 15 mM HCl and 300 μl 7.5 mM NaOH. When bath incubation for brain slices was used, a 1:780 dilution was prepared to achieve the final concentration of 100 nM. Picrotoxin (100 μM) (PTX, TOCRIS 1128) was added to block ionotropic GABA A receptors. For inhibitory hM4Di-related assays, clozapine-N-oxide (CNO, 10 μM, NIH Drug Supply Program) was added to the bath solution. To assess IPSCs paired-pulse ratio, pairs of electrical microstimulation pulses were delivered at 50-ms inter-pulse intervals and selected low threshold to ensure recovery of the presynaptic terminals (30 s interval). Recordings were made using an Axoclamp 700B amplifier (Axon Instruments) at room temperature. Data were filtered at 3 kHz and sampled at 10 kHz. Series resistance, measured with a 5-mV hyperpolarizing pulse in voltage clamp, was on average under 20 MΩ and less than 25 MΩ, uncompensated. All voltage-clamp recordings were made from cells held at −60 mV. For current-clamp recordings, membrane potentials were corrected for a ~8 mV liquid junction potential. Immunohistochemistry. Immunohistochemistry was performed as previously described 39 . In brief, mice were transcardially perfused with 10% formalin and the brains were post-fixed for 1-2 days. Brains were sectioned coronally at 40 μm using a Leica microtome (Leica SM2010R). Brain sections were washed in PBS with 0.25% Triton X-100 (PBT, pH 7.4) and incubated in 3% normal donkey serum (Jackson ImmunoResearch Laboratories, 017-000-121) in PBT-azide for 2 h. Slides were then incubated overnight at room temperature in a primary antiserum. After washing in PBS, sections were incubated in fluorescein-conjugated donkey IgG. . For FOS and pS6 staining following leptin treatment, leptin (5 mg/kg) was intraperitoneally injected in STZ-treated mice, and mice were perfused 3 h later. For pSTAT3 staining, mice were fasted overnight for 24 h, followed by 5 mg/kg intraperitoneal leptin injection 40 . Forty-five minutes later, mice were perfused and brains were dissected out. Following PBS washes Letter reSeArCH (3 × 10 min), brain slices were pre-treated with 1% NaOH for 15 min as previously described. Brain sections were mounted onto SuperFrost (Fisher Scientific 22-034-980) slides and then visualized with a Leica TCS SPE Confocal Microscope (Leica Microsystems) using 10 × , 20 × oil immersion, or 63 × oil immersion, or Olympus VS120 Virtual Slide Microscope (Olympus) for whole-brain scanning. Images were imported into ImageJ or Fiji (NIH) software for further analysis. RNA in situ hybridization. RNA in situ hybridization (ISH) was performed using RNAscope 2.5 HD Assay-Brown kit (acdbio, 322300). In brief, mice were transcardially perfused with 4% paraformaldehyde (PFA) and the brains were post-fixed for 1-2 days. Brain samples were sectioned coronally at 15 μm using a Thermo Scientific cryostat microtome (Thermo Scientific, HM 525) and mounted on SuperFrost Plus slides (Fisher Scientific, 12-550-15) . Slides were washed for 5 min with PBS and treated with hydrogen peroxide for 10 min. After washing in distilled water, slides were submerged into boiling 1× retrieval solution for 5 min and washed with distilled water. A hydrophobic barrier was then created and the probe against Lepr mRNA (Advanced Cell Diagnostics, 402731, Mm-Lepr) was added onto slides. After 2 h incubation at 40 °C, Hybridize-Amp probes #1-6 were applied on slides sequentially to amplify signals. Finally, DAB was added onto slides to visualize signals and a VS120 Virtual Slide Microscope (Olympus) was used for whole-brain scanning. Food intake, body weight and body composition analysis. Food intake, body weight and body composition studies were performed as previously described 39 . For daily food intake assays, food pellets were weighed at 10:00 each day for four continuous days and an average of three-day food intake was calculated. Lightcycle food intake was measured between 07:00 and 19:00 and dark-cycle food intake was measured between 19:00 and 07:00. For virus-transduced knockout experiments, animals were singly housed for one week after surgery and maintained for two weeks to allow sufficient expression of AAV-expressed transgene. Body weight and food intake were measured weekly, including the week before surgery. For inhibitory hM4Di-related studies, mice were singly housed and food pellets were weighed before and after intraperitoneal injection of CNO (0.3 mg/kg) during light cycle (10:00 to 14:00) or dark cycle (20:00 to 00:00). For studies in NOD mice, body weight and food intake were measured from three months of age, before the majority of diabetes symptoms develop 33 . For Lepr db/db mice, food intake and body weight were tracked from four weeks of age. Body fat mass was measured using echoMRI analysis, and oxygen consumption was measured using metabolic chambers of a Comprehensive Laboratory Animal Monitoring System (CLAMS, Columbus Instruments) from the Adipose Tissue Biology and Nutrient Metabolism Core at the Boston Nutrition and Obesity Research Center (BNORC). Mice were acclimatized in the chambers for 48 h before data collection. Mice with 'missed' injections or incomplete 'hits' were excluded from analysis after post hoc examination of mCherry or GFP expression. In this way, all measurements were randomized and experimenters were blind to treatments. Blood glucose, glucose and insulin tolerance test. Blood glucose concentrations were measured using a blood glucose meter and glucose test strips (OneTouch Ultra). For virus-induced knockout experiments, blood glucose was measured weekly following surgery. For inhibitory DREADDs (designer receptors exclusively activated by designed drugs) studies, food pellets were removed 2 h before CNO injection. Blood glucose was measured at 0, 1, 2, 4 and 6 h without food following CNO treatment. For glucose tolerance tests (GTT), mice were fasted overnight. After the fasting period, mice received an intraperitoneal injection of 20% glucose (1 g/kg) and blood glucose levels were measured at 0, 15, 30, 60 and 120 min time points post-glucose injection. For insulin tolerance tests (ITT), mice were fasted for 4 h and blood glucose levels were measured at 0, 15, 30, 60, and 120 min time points following. intraperitoneal injection of insulin (0.75 U/kg). STZ treatment. STZ (Sigma-Aldrich Cat#S0130) was injected intraperitoneally in C57BL/6 mice at varying doses from 75 to 150 mg/kg. STZ injection of 125 mg/kg was selected for subsequent experiments to induce gradual onset of hyperglycaemia and characteristic diabetic symptoms. Health conditions were closely monitored twice a day for two days following STZ injection. Three days after injection, blood glucose was measured to assess the extent of STZ-induced diabetes. Other metabolic studies included monitoring of body weight, food intake, micturition analysis, serum insulin and serum leptin levels. Leptin effects on body weight and food intake. The effects of leptin on body weight and food intake were assessed as described 40 . In brief, mice (6-7 weeks old) were individually housed and acclimated to handling for one week. These mice were then injected intraperitoneally with saline (0.9% NaCl) or leptin (2 mg/kg per injection, at 07:00 and 19:00) every 12 h for 3 days. Body weight and food intake were measured at baseline and on each day on which saline injections or leptin injections were administered. Body weight and food intake were averaged during the three days before injections to obtain baseline values used for calculating per cent changes. To assess leptin's ability to acutely suppress hunger-induced appetite, mice were singly housed and fasted for 24 h. On the second day, a high dose of leptin (5 mg/kg) was injected intraperitoneally in mice at 07:00 and pre-weighed food was placed back in the cage and monitored for the following 24 h. Osmotic pump. Intracerebroventricular (i.c.v.) cannula minipump implantation was performed as previously described 11 . In brief, a cannula was implanted into the cerebral lateral ventricle (AP: −0.50 mm, ML: ± 1.3 mm, DV: −2.3 mm), and a mini-osmotic pump (model 1007D, Alzet) was implanted subcutaneously via a catheter connected to the cannula for i.c.v. infusion. The mini-osmotic pump was filled with either leptin (454 ng/μl) or sterile saline solution. Food intake, body weight and glucose were measured on days 1, 3, 5 and 7 post-surgery. Serum leptin and insulin measurement. Tail vein blood was collected for ELISA assays as previously described 11 . In brief, about 20-50 μl tail vein blood was collected from mice that were food restricted for 2 h before blood collection. Blood was collected with heparinized capillary tubes (Fisher Scientific, 22-260-950) and then centrifuged at 3,000g for 20 min to collect serum and stored at −80 °C. For insulin levels, Ultra Sensitive Mouse Insulin ELISA Kit (Crystal Chem, 90080) was used. For leptin levels, Mouse Leptin ELISA Kit (Crystal Chem, 90030) was used. Reverse transcription and quantitative PCR assay. Brains were dissected and preserved in RNAlater solution (Thermo Fisher Scientific, AM7020). Total RNA was extracted using TRIzol Reagent (Thermo Fisher Scientific, 15596-018) and reverse transcribed using AffinityScript QPCR cDNA Synthesis Kit (Agilent Technologies #600559). TaqMan probes (all from Applied Biosystems, catalogue number in parentheses) used for quantitative PCR (qPCR) include those for Agrp (Mm00475829_g1), Npy (Mm00445771_m1), and Pomc (Mm01323842_m1), Lepr (Mm00440181_m1). Expression of the genes was normalized to that of 18 S ribosomal RNA (Applied Biosystems, 4319413E). qPCR was performed on a StepOnePlus Real-Time PCR System (Applied Biosystems). Behavioural assays and video analysis. Mice were placed in a 25 × 40 × 20-cm arena to assess feeding duration and 1-h food intake during the light phase (10:00−11:00). Food and nest zones were designated at opposite ends of the arena. A food bowl containing standard chow diet was placed. The spatial locations were tracked and analysed using EthoVision XT 10 software (Noldus) and CCD cameras (Motic). Thermal imaging of brown adipose tissue. Thermal imaging was performed using a calibrated thermal imaging camera attachment (FLIR One). Mice were anaesthetized and the fur on their back covering the interscapular brown adipose tissue (iBAT) area was shaved. After a one-week recovery and acclimation period, freely moving mice were thermally imaged and their subcutaneous iBAT temperatures were calculated accordingly. Thermal signals from the flank area were used as control. Cell culture and indel analysis. Neuro-2a (N2a) cells (ATCC, CCL131) were cultured in Dulbecco's modified Eagle's medium (Sigma-Aldrich, D8437) supplemented with 10% fetal bovine serum (Thermo Fisher, 16000044), 500 μg/ml penicillin-streptomycin-glutamine (Thermo Fisher, 10378016) at 37 °C with 5% CO 2 . Cells were routinely tested for mycoplasma using PCR detection kit (ATCC, 30-1012 K). Indel analysis was performed with the GeneArt Genomic Cleavage Detection Kit (Thermo Fisher, A24372). In brief, the U6-sgLepr cassette was cloned into the pCas9-GFP backbone (Addgene, 44719) following MluI (New England Biolabs, R3198S) digestion. Cells were transfected with Lipofectamine 3000 (Thermo Fisher, L3000008) and GFP fluorescence was used to assess the transfection efficiency after 48 h. Genomic DNA was extracted and PCR amplification was performed using the following primers: Lepr on-target primer forward, cttctctggaaggtagacgctc; reverse, gaccttgctcattcccaaag; Gpr108 off-target forward, tgagagtcagccggtggata; reverse, atgcttcgttgcacggatct. PCR products were digested with detection enzyme and analysed by DNA gel electrophoresis. Cleavage efficiency was calculated as: cleavage efficiency = 1-[(1-fraction cleaved) 1/2 ], where fraction cleaved = sum of cleaved band intensities/(sum of the cleaved and parental band intensities). Data analysis. Offline data analysis for electrophysiology was performed using custom scripts in Igor Pro 6 (Wavemetrics) and MATLAB (MathWorks). Statistical analyses were performed using Prism 6 (GraphPad). Imaging data analyses were performed with ImageJ (NIH). For imaging results of FOS staining, ImageJ was used to convert original fluorescent images following a three-step method (grays, invert LUT, merge channels). All values are reported as mean ± s.e.m. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data and code availability. The original and/or analysed datasets generated during the current study, and the codes used to analyse them, are available from the corresponding author upon reasonable request. 
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Extended Data Fig. 2 | Characterization of feeding behaviours in STZtreated diabetic mice. Additional analyses of ectopic activation of AGRP neurons and its pathologic contributions to STZ-induced hyperphagia and hyperglycaemia. a, Quantitative PCR results showing that expression of Agrp and Npy is significantly upregulated in the mediobasal hypothalamus of STZ-treated animals, which is consistent with increased AGRP neuronal activity following STZ injection (n = 5 mice per group). b-f, Food intake during light cycle (07:00 to 19:00) (b) and dark cycle (19:00 to 07:00) (c), representative 1-h heat map (10:00 to 11:00) showing per cent occupancy time in food zone (upper right corner) and nesting zone (lower right corner) (d), feeding duration (e), and 1-h food intake (f) in saline-or STZ-treated C57BL/6 mice (n = 8 mice per group). g, h, Representative sections and quantification of hrGFP immunostaining in the ARC of saline-or STZ-treated Npy-hrGFP transgenic mice, suggesting that STZ treatment does not induce obvious loss of AGRP neurons (n = 3 mice per group). i, Representative sections and quantification of hrGFP and pS6 co-immunostaining in the ARC of saline-or STZ-treated Npy-hrGFP transgenic mice (n = 4 mice per group). j, Schematic of chemogenetic inhibition of AGRP neurons in virus-transduced Agrp-IRES-cre mice. k, Four-hour food-intake measurement during dark cycle (20:00 to 00:00) following the administration of saline or CNO (n = 6 mice per group). l, m, Four-hour food-intake assay (10:00 to 14:00) (l) and blood glucose measurement (m, without food in the cage) in saline-or CNO-treated female Agrp-IRES-cre littermates that had been injected with AAV pSyn-FLEX-hM4Di-mCherry virus into the ARC, (n = 8 mice per group). n-q, Schematic of experiments to assess effects of CNO on Agrp-IRES-cre mice injected with Cre-dependent AAV-FLEX-mCherry virus in the ARC (n). Representative brain sections (o) and quantification (p, n = 3 mice per group) of mCherry and FOS co-immunostaining, and food intake assay (q; 10:00 to 14:00, n = 8 mice per group) in STZ-treated mice following intraperitoneal injection of saline or CNO, demonstrating that CNO administration without hM4Di expression in AGRP neurons has no effect and the changes observed in Fig. 1g -i are caused by the chemogenetic inhibition of AGRP neurons. Data are mean ± s.e.m. and representative of three independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; Student's two-tailed, unpaired t-test (a-c, e, f, h, p) , paired t-test (m) or two-way ANOVA analysis (l, q) with Šidák post hoc test (k). Expression of a CRISPR-insensitive Kir6.2 in AGRP neurons prevents alterations in body weight, food intake or blood glucose following CRISPR-mediated deletion. a, Representative images and quantification of mCherry and pSTAT3 co-immunostaining (n = 4 mice per group) following CRISPR-mediated disruption of Kcnj11 in AGRP neurons. b, Experimental protocol to test chronic effects of leptin on regulation of body weight and food intake. c, sgRNA design targeting the mouse Kcnj11 locus and CRISPR-insensitive Kcnj11 cDNA encoding the mouse K ATP channel subunit Kir6.2 (ciKcnj11) with indicated silent mutations to prevent binding of sgRNA. d, Schematic of Cre-dependent AAV pEF1α-FLEX-ciKcnj11-IRES-mCherry (AAV-FLEX-ciKcnj11) injected unilaterally into the ARC of Agrp-IRES-cre::Lepr db/db mice and representative image of mCherry immunostaining. e-h, Experimental protocol (e), body weight (f), daily food intake (g) and blood glucose measurements (h) in virus-transduced ad libitum-fed littermates (n = 8 mice per group). Expression of ciKcnj11 in AGRP neurons completely prevented body weight gain, increased food intake and hyperglycaemia induced by CRISPR-mediated deletion, suggesting that contributions from off-site mutagenesis are excluded. i-k, Body weight (i), food intake (j), and blood glucose (k) of non-cre and Agrp-IRES-cre littermates following bilateral injection of AAV-FLEX-ciKcnj11 into the ARC (n = 8 mice per group), suggesting that AAV-mediated expression of ciKcnj11 in AGRP neurons produces no obvious effects on energy or glucose balances. Data are mean ± s.e.m. and representative of three independent experiments; ***P < 0.001, ****P < 0.0001; Student's two-tailed, unpaired t-test (a, g, h, j) or two-way ANOVA (f, i, k). of sEPSCs were observed in AGRP neurons at a later stage following GABA A receptor deletion, together with concurrent elimination of the observed disinhibition of these neurons (c), body weight gain (a) and hyperphagia (b), suggesting that excitatory and inhibitory afferents cooperate dynamically to modulate AGRP neuronal activities. In addition, the compensatory reduction in sEPSCs in virus-transduced neurons but not in the neurons from the contralateral side also indicates a cellautonomous mechanism. Data are mean ± s.e.m. and representative of three independent experiments; **P < 0.01, ****P < 0.0001; Student's two-tailed, unpaired t-test (b, d, e) or two-way ANOVA with Šidák post hoc test (a). Corresponding author(s): Dong Kong, PhD
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Data exclusions
Describe any data exclusions. As stated in the methods section under 'Stereotaxic surgery', all stereotaxic injection sites were verified under electrophysiological microscopy (for electrophysiology-related studies) or by immunohistochemistry (for anatomy and in vivo studies). All 'missed' or 'partial-hit' animals were excluded from data analyses. For the experiment in figure 3b, silent neurons (which showed no depolarization before diazoxide apply) were excluded from data analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
All experimental findings were reliably reproduced.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For data analyses, all animals of the same sex were independently housed and randomly assigned to either experimental or control groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Due to the nature of stereotaxic injection and analysis of viral hits (including 'missed' injections or 'incomplete' hits which were later excluded after post hoc analysis of mCherry or GFP expression), all measurements were randomized and blind to the experimenter.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Offline data analysis for electrophysiology was performed by using previously published custom scripts written in Igor Pro 6 (Wavemetrics) and MATLAB (MathWorks). Statistical analyses were performed using GraphPad PRISM 6 software (GraphPad). Imaging data analysis was performed using ImageJ (NIH).
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There is no restriction on material availability. We include a statement on data availability in our manuscript, as required by Nature policy.
